You are here: Home > News > Combining Engineered Antibodies and Marine Products for Biotherapeutics and Diagnostics

Combining Engineered Antibodies and Marine Products for Biotherapeutics and Diagnostics

08.05.2012, Dublin (Ireland)

This conference is of high interest for institutions dedicated to the study of marine organisms, pharmaceutical companies as well for Authorities from Atlantic Area. It will highlight the achievements of the PHARMATLANTIC consortium, an EU-funded group, whose aims are focused on the effects of climate change on the production of marine compounds and toxins in the Atlantic area. The partners of this project have already grown, purified and developed models to test the activity of compounds/toxins and are examining their possible applications in a variety of areas including cancer therapy, immunomodulation and neurological diseases. You can download here the conference programme.

The project PHARMATLANTIC (Knowledge Transfer Network for Prevention of Mental Diseases and Cancer in the Atlantic Area), leaded by the University of Santiago de Compostela (Spain), is funded by the Atlantic Area Transnational Cooperation Programme 2007-2013 and it counts with the participation of institutions from different countries of the Atlantic Area.

For further information please contact: Paz Otero Mariapaz.otero@rai.usc.es

 

Document Actions